Medical Devices industry deals total $2.8bn globally in March 2022

Total medical devices industry deals worth $2.8bn were announced globally for March 2022, with the $240m acquisition of Ivenix being the sector’s biggest investment, according to GlobalData’s deals database.

The value marked a decrease of 33.02% over the previous month of $4.21bn and a drop of 82.7% when compared with the last 12-month average of $16.26bn.

In terms of number of deals, the sector saw a rise of 1.52% with 200 deals in March 2022 when compared to the last 12-month average of 197 deals.

In value terms, North America led the activity with deals worth $1.87bn in March 2022.

medical devices industry deals in March 2022: Top deals

The top five deals accounted for 28% of the overall value during March 2022.

The combined value of the top five deals stood at $790m, against the overall value of $2.8bn recorded for the month.

The top five medical devices industry deals of March 2022 tracked by GlobalData were:

1) Fresenius Kabi $240m acquisition deal with Ivenix

2) The $200m venture financing of DNAnexus by Blackstone Growth,Foresite Capital Management,GV Management Co,Innovatus Capital Partners,Northpond Ventures and Perceptive Advisors

3) Fidelity Management & Research,Redmile Group and T Rowe Price Associates $125m private equity deal with Saluda Medical

4) The $125m venture financing of BillionToOne by Adams Street Partners,Baillie Gifford,Civilization Ventures,Fifty Years Fund,Hummingbird Ventures,Libertus Capital,NeoTribe Ventures,Norwest Venture Partners,Pacific 8 Ventures and Time BioVentures

5) Artiman Ventures,Blue Water Life Science Advisors,Cedars-Sinai Medical Center,Healthcare of Ontario Pension Plan,John Doerr,ND Capital,Nissim Capital,Ping An Voyager Partners and Pitango Venture Capital $100m venture financing deal with Visby Medical